ETIDIOH - NEW

  Situation at a glance On 4 August 2025, Israel notified WHO of a circulating vaccine-derived poliovirus type 1 (cVDPV1) outbreak .  Between February and July 2025, nine genetically linked virus isolates were found in environmental samples from seven sites, mainly in Jerusalem and the Central Region .  No human cases of paralytic polio have been reported.  Israel discontinued routine use of the bivalent oral polio vaccine in March 2025 but continues using inactivated polio vaccine (IPV) as part of the country’s routine immunization schedule.  WHO and partners of the Global Polio Eradication Initiative are supporting national and subnational authorities.  WHO assesses the risk of international spread of this cVDPV1 outbreak in Israel as low, due to strong overall immunity, surveillance, and response systems.  However, the virus is circulating in under-vaccinated, vaccine-sceptic communities with ties to similar groups abroad, posing a potential risk fo...

{Excerpts} The 41st meeting of the Emergency Committee under the International Health Regulations (2005) (IHR) on the international spread of poliovirus was convened by the WHO Director-General on 6 March 2025 with committee members and advisers meeting via video conference with affected countries, supported by the WHO Secretariat.   The Emergency Committee reviewed the data on wild poliovirus (WPV1) and circulating vaccine derived polioviruses (cVDPV) in the context of the global target of interruption and certification of WPV1 eradication by 2027 and interruption and certification of cVDPV2 elimination by 2029.  Technical updates were received about the situation in the following countries:  - Afghanistan,  - Algeria,  - Chad,  - Democratic Republic of the Congo (DR Congo),  - Djibouti,  - Ethiopia,  - Germany,  - Pakistan,  - Poland and  - the United Kingdom of Great Britain and Northern Ireland. (...) Based on the curr...